Pacira BioSciences (PCRX) Free Cash Flow (2010 - 2026)
Pacira BioSciences (PCRX) posted quarterly Free Cash Flow of $24.3 million for Q1 2026, down 29.9% year-over-year from $34.7 million in Q1 2025, and down 44.06% quarter-over-quarter from $43.5 million in Q4 2025.
Pacira BioSciences (PCRX) Free Cash Flow (2010 - 2026) Analysis & Trends
Pacira BioSciences' Free Cash Flow history runs 17 years deep, the most recent figure standing at $24.3 million for Q1 2026.
- In Q1 2026, Free Cash Flow fell 29.9% year-over-year to $24.3 million; the TTM figure through Mar 2026 stood at $126.3 million (down 25.72% YoY), while the FY2025 annual figure was $136.7 million, down 25.66% from the prior year.
- Free Cash Flow for Q1 2026 stood at $24.3 million, down from $43.5 million in the prior quarter.
- The five-year high for Free Cash Flow was $57.0 million in Q3 2025, with the low at $1.5 million in Q2 2025.
- The 5-year median for Free Cash Flow is $36.5 million (2022), against an average of $35.3 million.
- The sharpest annual moves came in 2022 and 2025: Free Cash Flow surged 2573.08% in 2022, then plunged 96.9% in 2025.
- Pacira BioSciences' Free Cash Flow stood at $36.5 million in 2022, then fell by 7.26% to $33.9 million in 2023, then climbed by 6.47% to $36.1 million in 2024, then grew by 20.47% to $43.5 million in 2025, then slumped by 44.06% to $24.3 million in 2026.
- Business Quant data shows PCRX's Free Cash Flow at $24.3 million in Q1 2026, $43.5 million in Q4 2025, and $57.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 307.00 Mn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 538.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 1.14 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 205.60 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 329.00 Mn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 128.60 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 244.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Pacira BioSciences | 970.37 Mn | 719.34 Mn | 148.24 Mn | 56.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 56.12 Mn |
| Jun 30, 2026 | 56.12 Mn |
| Mar 31, 2026 | 24.32 Mn |
| Mar 31, 2026 | 24.32 Mn |
| Dec 31, 2025 | 43.47 Mn |
| Dec 31, 2025 | 43.47 Mn |
| Sep 30, 2025 | 56.96 Mn |
| Sep 30, 2025 | 56.96 Mn |
| Jun 30, 2025 | 1.53 Mn |
| Jun 30, 2025 | 1.53 Mn |
| Mar 31, 2025 | 34.69 Mn |
| Mar 31, 2025 | 34.69 Mn |
| Dec 31, 2024 | 36.09 Mn |
| Dec 31, 2024 | 36.09 Mn |
| Sep 30, 2024 | 49.83 Mn |
| Sep 30, 2024 | 49.83 Mn |
| Jun 30, 2024 | 49.42 Mn |
| Jun 30, 2024 | 49.42 Mn |
| Mar 31, 2024 | 48.49 Mn |
| Mar 31, 2024 | 48.49 Mn |